The Spinal Cord Injury (SCI) program entitled “Development of Antisense Therapy of Spinal Cord Injury” has been approved to achieve the goal of the development by the Ex-post evaluation of the Japan Agency for Medical Research and Development (AMED).

AMED adopted the program as the 4th Cyclic Innovation for Clinical Empowerment (CiCLE, Start-up type; ViCLE).

Please click here (go to the web page of the Japan Agency for Medical Research and Development) for more information (Japanese only).